Impact of Fentanyl and Remifentanil on Immune Response in Breast Cancer Patients Post-surgery
Optimizing analgesic selection and anesthesia duration may play a crucial role in minimizing immunosuppressive perioperative stress in patients undergoing BCa surgery. Remifentanil combined with shorter anesthesia exposure appears to mitigate immune suppression, suggesting a potential strategy to preserve immune competence during oncologic surgery.
Authors
- Pelagia A Chloropoulou
- Alexandra Giatromanolaki (ORCID: https://orcid.org/0000-0003-3706-8845)
- Michael I. Koukourakis (ORCID: https://orcid.org/0000-0002-2324-699X)
- Erasmia Xanthopoulou
- Eleni Efraimidou
- Maria Zachou (ORCID: https://orcid.org/0000-0001-5156-9553)
- Grigorios Lyronis
- Antigoni Kaprana
Institutions
- Democritus University of Thrace (GR)
- Ruhr West University of Applied Sciences (DE)
- Städtische Kliniken Mönchengladbach (DE)
- University Hospital of Alexandroupolis (GR)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-08-28
- DOI
- https://doi.org/10.21873/anticanres.17736
- Citations
- 1
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Trakya Üniversitesi